Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy

INTRODUCTION: The Livial Intervention Following Breast Cancer: Efficacy, Recurrence and Tolerability Endpoints (LIBERATE: Clinical http://Trials.gov number NCT00408863), a randomized, placebo-controlled, double-blind trial that demonstrated that tibolone (Livial), a tissue-selective hormone-replacem...

詳細記述

保存先:
書誌詳細
主要な著者: Bundred, Nigel J, Kenemans, Peter, Yip, Cheng Har, Beckmann, Matthias W, Foidart, Jean-Michel, Sismondi, Piero, Schoultz, Bo von, Vassilopoulou-Sellin, Rena, Galta, Rachid El, Lieshout, Eugenie Van, Mol-Arts, Mirjam, Planellas, Juan, Kubista, Ernst
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2012
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3496130/
https://ncbi.nlm.nih.gov/pubmed/22251615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3097
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料